Autoimmune Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510242402

Publication Date:

October 17, 2024

Pages:

114

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Autoimmune Disease Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Autoimmune Disease Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autoimmune Disease Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Autoimmune Disease Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Autoimmune Disease Testing include F.Hoffmann-La Roche Ltd, ZEus Scientific, Inc., Thermo Fisher Scientific Inc., QuestDiagnostics Incorporated, Abbott, Ql Diagnostics Inc, Werfen, Trinity Biotech and KsL Beutner Laboratories (Beutner), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Autoimmune Disease Testing by region & country, by Type, and by Application.
The Autoimmune Disease Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Testing.
Market Segmentation
By Company
F.Hoffmann-La Roche Ltd
ZEus Scientific, Inc.
Thermo Fisher Scientific Inc.
QuestDiagnostics Incorporated
Abbott
Ql Diagnostics Inc
Werfen
Trinity Biotech
KsL Beutner Laboratories (Beutner)
Bio-Rad Laboratories
Segment by Type:
Instrument
Reagent Consumables
Segment by Application
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Scleroderma
Vasculitis
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Autoimmune Disease Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Autoimmune Disease Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Autoimmune Disease Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Autoimmune Disease Testing Product Introduction
1.2 Global Autoimmune Disease Testing Market Size Forecast
1.3 Autoimmune Disease Testing Market Trends & Drivers
1.3.1 Autoimmune Disease Testing Industry Trends
1.3.2 Autoimmune Disease Testing Market Drivers & Opportunity
1.3.3 Autoimmune Disease Testing Market Challenges
1.3.4 Autoimmune Disease Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Autoimmune Disease Testing Players Revenue Ranking (2023)
2.2 Global Autoimmune Disease Testing Revenue by Company (2019-2024)
2.3 Key Companies Autoimmune Disease Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Autoimmune Disease Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Autoimmune Disease Testing
2.6 Autoimmune Disease Testing Market Competitive Analysis
2.6.1 Autoimmune Disease Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Autoimmune Disease Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Instrument
3.1.2 Reagent Consumables
3.2 Global Autoimmune Disease Testing Sales Value by Type
3.2.1 Global Autoimmune Disease Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Autoimmune Disease Testing Sales Value, by Type (2019-2030)
3.2.3 Global Autoimmune Disease Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Rheumatoid Arthritis
4.1.2 Systemic Lupus Erythematosus
4.1.3 Scleroderma
4.1.4 Vasculitis
4.1.5 Other
4.2 Global Autoimmune Disease Testing Sales Value by Application
4.2.1 Global Autoimmune Disease Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Autoimmune Disease Testing Sales Value, by Application (2019-2030)
4.2.3 Global Autoimmune Disease Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Autoimmune Disease Testing Sales Value by Region
5.1.1 Global Autoimmune Disease Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Autoimmune Disease Testing Sales Value by Region (2019-2024)
5.1.3 Global Autoimmune Disease Testing Sales Value by Region (2025-2030)
5.1.4 Global Autoimmune Disease Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Autoimmune Disease Testing Sales Value, 2019-2030
5.2.2 North America Autoimmune Disease Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Autoimmune Disease Testing Sales Value, 2019-2030
5.3.2 Europe Autoimmune Disease Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Autoimmune Disease Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Autoimmune Disease Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Autoimmune Disease Testing Sales Value, 2019-2030
5.5.2 South America Autoimmune Disease Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Autoimmune Disease Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Autoimmune Disease Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Autoimmune Disease Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Autoimmune Disease Testing Sales Value
6.3 United States
6.3.1 United States Autoimmune Disease Testing Sales Value, 2019-2030
6.3.2 United States Autoimmune Disease Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Autoimmune Disease Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Autoimmune Disease Testing Sales Value, 2019-2030
6.4.2 Europe Autoimmune Disease Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Autoimmune Disease Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Autoimmune Disease Testing Sales Value, 2019-2030
6.5.2 China Autoimmune Disease Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Autoimmune Disease Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Autoimmune Disease Testing Sales Value, 2019-2030
6.6.2 Japan Autoimmune Disease Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Autoimmune Disease Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Autoimmune Disease Testing Sales Value, 2019-2030
6.7.2 South Korea Autoimmune Disease Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Autoimmune Disease Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Autoimmune Disease Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Autoimmune Disease Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Autoimmune Disease Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Autoimmune Disease Testing Sales Value, 2019-2030
6.9.2 India Autoimmune Disease Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Autoimmune Disease Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 F.Hoffmann-La Roche Ltd
7.1.1 F.Hoffmann-La Roche Ltd Profile
7.1.2 F.Hoffmann-La Roche Ltd Main Business
7.1.3 F.Hoffmann-La Roche Ltd Autoimmune Disease Testing Products, Services and Solutions
7.1.4 F.Hoffmann-La Roche Ltd Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.1.5 F.Hoffmann-La Roche Ltd Recent Developments
7.2 ZEus Scientific, Inc.
7.2.1 ZEus Scientific, Inc. Profile
7.2.2 ZEus Scientific, Inc. Main Business
7.2.3 ZEus Scientific, Inc. Autoimmune Disease Testing Products, Services and Solutions
7.2.4 ZEus Scientific, Inc. Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.2.5 ZEus Scientific, Inc. Recent Developments
7.3 Thermo Fisher Scientific Inc.
7.3.1 Thermo Fisher Scientific Inc. Profile
7.3.2 Thermo Fisher Scientific Inc. Main Business
7.3.3 Thermo Fisher Scientific Inc. Autoimmune Disease Testing Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Inc. Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.3.5 QuestDiagnostics Incorporated Recent Developments
7.4 QuestDiagnostics Incorporated
7.4.1 QuestDiagnostics Incorporated Profile
7.4.2 QuestDiagnostics Incorporated Main Business
7.4.3 QuestDiagnostics Incorporated Autoimmune Disease Testing Products, Services and Solutions
7.4.4 QuestDiagnostics Incorporated Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.4.5 QuestDiagnostics Incorporated Recent Developments
7.5 Abbott
7.5.1 Abbott Profile
7.5.2 Abbott Main Business
7.5.3 Abbott Autoimmune Disease Testing Products, Services and Solutions
7.5.4 Abbott Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Abbott Recent Developments
7.6 Ql Diagnostics Inc
7.6.1 Ql Diagnostics Inc Profile
7.6.2 Ql Diagnostics Inc Main Business
7.6.3 Ql Diagnostics Inc Autoimmune Disease Testing Products, Services and Solutions
7.6.4 Ql Diagnostics Inc Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Ql Diagnostics Inc Recent Developments
7.7 Werfen
7.7.1 Werfen Profile
7.7.2 Werfen Main Business
7.7.3 Werfen Autoimmune Disease Testing Products, Services and Solutions
7.7.4 Werfen Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Werfen Recent Developments
7.8 Trinity Biotech
7.8.1 Trinity Biotech Profile
7.8.2 Trinity Biotech Main Business
7.8.3 Trinity Biotech Autoimmune Disease Testing Products, Services and Solutions
7.8.4 Trinity Biotech Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Trinity Biotech Recent Developments
7.9 KsL Beutner Laboratories (Beutner)
7.9.1 KsL Beutner Laboratories (Beutner) Profile
7.9.2 KsL Beutner Laboratories (Beutner) Main Business
7.9.3 KsL Beutner Laboratories (Beutner) Autoimmune Disease Testing Products, Services and Solutions
7.9.4 KsL Beutner Laboratories (Beutner) Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.9.5 KsL Beutner Laboratories (Beutner) Recent Developments
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Profile
7.10.2 Bio-Rad Laboratories Main Business
7.10.3 Bio-Rad Laboratories Autoimmune Disease Testing Products, Services and Solutions
7.10.4 Bio-Rad Laboratories Autoimmune Disease Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Bio-Rad Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Autoimmune Disease Testing Industrial Chain
8.2 Autoimmune Disease Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Autoimmune Disease Testing Sales Model
8.5.2 Sales Channel
8.5.3 Autoimmune Disease Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

F.Hoffmann-La Roche Ltd
ZEus Scientific, Inc.
Thermo Fisher Scientific Inc.
QuestDiagnostics Incorporated
Abbott
Ql Diagnostics Inc
Werfen
Trinity Biotech
KsL Beutner Laboratories (Beutner)
Bio-Rad Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂